Neuropeptides modulate human eosinophil chemotaxis

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

To investigate the role of neuropeptides in allergic inflammation, we examined the effect of peptides on eosinophil chemotaxis. Eosinophils were purified from the blood of allergic and normal subjects using a discontinuous Percoll density gradients. Chemotaxis was induced by platelet-activating factor (PAF) and leukotriene B4, and was assayed by a modified Boyden's chamber technique. Four neuropeptides were examined in this study: substance P (SP), neurokinin A, calcitonin gene-related peptide (CGRP), and cholecystokinin octapeptide. Peptides alone (10 nM to 10 μM) were not chemotactic for eosinophils. However, when eosinophils were pre-treated with peptides (100 nM) at 37°C for 30 min, chemotactic response to PAF (10 nM) was significantly enhanced (p <0.01) in allergic subjects; % control by SP, neurokinin A, CGRP and cholecystokinin octapeptide was 269 ± 42, 243 ± 32, 227 ± 21, and 251 ± 42, respectively (n = 8). Similar results were obtained in leukotriene B4-induced eosinophil chemotaxis. In contrast, no enhancement was observed in normal subjects. Potentiating effect of SP and CGRP on PAF- induced eosinophil chemotaxis in allergic subjects was significantly attenuated by SP antagonist [D-Pro2,D-Trp7,9]-SP and human CGRP (8-37) receptor antagonist, respectively. Neutral endopeptidase inhibitors (phosphoramidon, leupeptin, and bestatin) failed to significantly augment the PAF-induced eosinophil chemotaxis when the cells were pretreated with various peptides and neutral endopeptidase inhibitors. The C-terminal fragment of SP (SP6-11) had an effect similar to that of the intact SP molecule, whereas no potentiating effect by the N-terminal of SP (SP1-9) was observed. These results suggest that neuropeptides may play a significant role in eosinophil infiltration by priming cells in allergic inflammation.

Original languageEnglish
Pages (from-to)3309-3315
Number of pages7
JournalJournal of Immunology
Volume149
Issue number10
StatePublished - 1992

Fingerprint

Chemotaxis
Substance P
Neuropeptides
Eosinophils
Platelet Activating Factor
Calcitonin Gene-Related Peptide
Neurokinin A
Neprilysin
Sincalide
Peptides
Leukotriene B4
Protease Inhibitors
Inflammation

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

Neuropeptides modulate human eosinophil chemotaxis. / Numao, T.; Agrawal, Devendra K.

In: Journal of Immunology, Vol. 149, No. 10, 1992, p. 3309-3315.

Research output: Contribution to journalArticle

@article{f2b57454703f41d78e92fbf4428270b6,
title = "Neuropeptides modulate human eosinophil chemotaxis",
abstract = "To investigate the role of neuropeptides in allergic inflammation, we examined the effect of peptides on eosinophil chemotaxis. Eosinophils were purified from the blood of allergic and normal subjects using a discontinuous Percoll density gradients. Chemotaxis was induced by platelet-activating factor (PAF) and leukotriene B4, and was assayed by a modified Boyden's chamber technique. Four neuropeptides were examined in this study: substance P (SP), neurokinin A, calcitonin gene-related peptide (CGRP), and cholecystokinin octapeptide. Peptides alone (10 nM to 10 μM) were not chemotactic for eosinophils. However, when eosinophils were pre-treated with peptides (100 nM) at 37°C for 30 min, chemotactic response to PAF (10 nM) was significantly enhanced (p <0.01) in allergic subjects; {\%} control by SP, neurokinin A, CGRP and cholecystokinin octapeptide was 269 ± 42, 243 ± 32, 227 ± 21, and 251 ± 42, respectively (n = 8). Similar results were obtained in leukotriene B4-induced eosinophil chemotaxis. In contrast, no enhancement was observed in normal subjects. Potentiating effect of SP and CGRP on PAF- induced eosinophil chemotaxis in allergic subjects was significantly attenuated by SP antagonist [D-Pro2,D-Trp7,9]-SP and human CGRP (8-37) receptor antagonist, respectively. Neutral endopeptidase inhibitors (phosphoramidon, leupeptin, and bestatin) failed to significantly augment the PAF-induced eosinophil chemotaxis when the cells were pretreated with various peptides and neutral endopeptidase inhibitors. The C-terminal fragment of SP (SP6-11) had an effect similar to that of the intact SP molecule, whereas no potentiating effect by the N-terminal of SP (SP1-9) was observed. These results suggest that neuropeptides may play a significant role in eosinophil infiltration by priming cells in allergic inflammation.",
author = "T. Numao and Agrawal, {Devendra K.}",
year = "1992",
language = "English",
volume = "149",
pages = "3309--3315",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Neuropeptides modulate human eosinophil chemotaxis

AU - Numao, T.

AU - Agrawal, Devendra K.

PY - 1992

Y1 - 1992

N2 - To investigate the role of neuropeptides in allergic inflammation, we examined the effect of peptides on eosinophil chemotaxis. Eosinophils were purified from the blood of allergic and normal subjects using a discontinuous Percoll density gradients. Chemotaxis was induced by platelet-activating factor (PAF) and leukotriene B4, and was assayed by a modified Boyden's chamber technique. Four neuropeptides were examined in this study: substance P (SP), neurokinin A, calcitonin gene-related peptide (CGRP), and cholecystokinin octapeptide. Peptides alone (10 nM to 10 μM) were not chemotactic for eosinophils. However, when eosinophils were pre-treated with peptides (100 nM) at 37°C for 30 min, chemotactic response to PAF (10 nM) was significantly enhanced (p <0.01) in allergic subjects; % control by SP, neurokinin A, CGRP and cholecystokinin octapeptide was 269 ± 42, 243 ± 32, 227 ± 21, and 251 ± 42, respectively (n = 8). Similar results were obtained in leukotriene B4-induced eosinophil chemotaxis. In contrast, no enhancement was observed in normal subjects. Potentiating effect of SP and CGRP on PAF- induced eosinophil chemotaxis in allergic subjects was significantly attenuated by SP antagonist [D-Pro2,D-Trp7,9]-SP and human CGRP (8-37) receptor antagonist, respectively. Neutral endopeptidase inhibitors (phosphoramidon, leupeptin, and bestatin) failed to significantly augment the PAF-induced eosinophil chemotaxis when the cells were pretreated with various peptides and neutral endopeptidase inhibitors. The C-terminal fragment of SP (SP6-11) had an effect similar to that of the intact SP molecule, whereas no potentiating effect by the N-terminal of SP (SP1-9) was observed. These results suggest that neuropeptides may play a significant role in eosinophil infiltration by priming cells in allergic inflammation.

AB - To investigate the role of neuropeptides in allergic inflammation, we examined the effect of peptides on eosinophil chemotaxis. Eosinophils were purified from the blood of allergic and normal subjects using a discontinuous Percoll density gradients. Chemotaxis was induced by platelet-activating factor (PAF) and leukotriene B4, and was assayed by a modified Boyden's chamber technique. Four neuropeptides were examined in this study: substance P (SP), neurokinin A, calcitonin gene-related peptide (CGRP), and cholecystokinin octapeptide. Peptides alone (10 nM to 10 μM) were not chemotactic for eosinophils. However, when eosinophils were pre-treated with peptides (100 nM) at 37°C for 30 min, chemotactic response to PAF (10 nM) was significantly enhanced (p <0.01) in allergic subjects; % control by SP, neurokinin A, CGRP and cholecystokinin octapeptide was 269 ± 42, 243 ± 32, 227 ± 21, and 251 ± 42, respectively (n = 8). Similar results were obtained in leukotriene B4-induced eosinophil chemotaxis. In contrast, no enhancement was observed in normal subjects. Potentiating effect of SP and CGRP on PAF- induced eosinophil chemotaxis in allergic subjects was significantly attenuated by SP antagonist [D-Pro2,D-Trp7,9]-SP and human CGRP (8-37) receptor antagonist, respectively. Neutral endopeptidase inhibitors (phosphoramidon, leupeptin, and bestatin) failed to significantly augment the PAF-induced eosinophil chemotaxis when the cells were pretreated with various peptides and neutral endopeptidase inhibitors. The C-terminal fragment of SP (SP6-11) had an effect similar to that of the intact SP molecule, whereas no potentiating effect by the N-terminal of SP (SP1-9) was observed. These results suggest that neuropeptides may play a significant role in eosinophil infiltration by priming cells in allergic inflammation.

UR - http://www.scopus.com/inward/record.url?scp=0026482757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026482757&partnerID=8YFLogxK

M3 - Article

C2 - 1385521

AN - SCOPUS:0026482757

VL - 149

SP - 3309

EP - 3315

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -